Загрузка...

Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale

Clinical and epidemiological studies of anticancer therapies increasingly seek to identify predictive biomarkers to obtain insights into variation in treatment benefit. For time to event endpoints, a predictive biomarker is typically assessed using the interaction between the biomarker and treatment...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Contemp Clin Trials
Главные авторы: Satagopan, Jaya M., Iasonos, Alexia
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568905/
https://ncbi.nlm.nih.gov/pubmed/28254404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.02.007
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!